Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Technology · CIK 0001308547
$62.31
+2.05% · delayed ~15 min
Last price from Oct 20, 2026
$5.97B market value
From Dolby Laboratories, Inc.'s FY2025 10-K, filed Nov 18, 2025 · read the filing
Dolby Laboratories invests in and manages other businesses. It took in $1.35B last year, which makes it a mid-sized company. Of every dollar it sells, about 19 cents is left as profit.
The financial picture is led by profitability, with growth and debt worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Generally healthy, with a few things to watch.
From Dolby Laboratories, Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Free cash flow
$297.2M → $435.9M
Cash
$482.0M → $701.9M
Capital spending
$30.0M → $36.3M
Revenue
$1.27B → $1.35B
Measured against FY2024, from the 10-K filed Nov 18, 2025
Improved: +46.6%
$297.2M to $435.9MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
How the latest move compares (quote delayed ~15 min), and what was published around it
DLB rose 2.05% on the latest quote. The average Financials company tracked here moved +1.11%, and the S&P 500 −1.04%. That is 0.9 points above its sector and 3.1 points above the market.
No filing from DLB and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 9 analysts covering this company, as of . Their views, not this site's.
Of 9 analysts publishing on this company, 3 say strong buy, 4 say buy and 2 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 19 cents of every dollar of sales as profit, earning $255.0M last year.
Slowly. Sales grew 5.9% last year.
For every $1 it owes, it owns $5.42 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 50 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 27% of the cash its operations generated. It has paid in each of the last 11 years.
GoodFigures from the FY2025 annual filing
Last year it earned $255.0M and generated $472.2M of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Nov 18, 2025Filing for FY2025 | FY202410-K · Nov 19, 2024Filing for FY2024 | FY202310-K · Nov 17, 2023Filing for FY2023 | FY202210-K · Nov 18, 2022Filing for FY2022 | FY202110-K · Nov 17, 2021Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B | +5.9% |
| Cost of revenue | $160.1M | $140.5M | $152.6M | $141.4M | $130.0M | +14.0% |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | $1.15B | +4.9% |
| Gross marginGross profit ÷ revenueWhat is this? | 88.1% | 89.0% | 88.3% | 88.7% | 89.9% | −0.8 pts |
| Selling, general and administrative | $286.5M | $270.4M | $258.5M | $275.3M | $224.2M | +6.0% |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M | +2.6% |
| Operating marginOperating income ÷ revenueWhat is this? | 19.6% | 20.3% | 16.6% | 16.5% | 26.9% | −0.6 pts |
| Interest expense | — | — | — | $394.0K | $479.0K | — |
| Income before tax | $303.5M | $312.5M | $250.1M | $215.3M | $354.5M | −2.9% |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M | $310.2M | −2.6% |
| Net marginNet income ÷ revenueWhat is this? | 18.9% | 20.6% | 15.4% | 14.7% | 24.2% | −1.7 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $2.66 | $2.74 | $2.10 | $1.84 | $3.07 | −2.9% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| DLBDolby Laboratories, Inc. · this page | 7.3/10 | 6/8 | 5.9% | 18.9% |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Exercised stock options — 7,667 shares at $45.50 ($348.8K)
Holds 174,470 shares after this filing.
Sold on the open market — 6,831 shares at $58.72 ($401.1K)
Holds 167,639 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Had a director or senior officer leave or join · Made a Regulation FD disclosure · Reported another event
Read the filingQuarterly report for Q3 FY2026
Operating margin −3.9 pts · Operating income -28.0% · Profit -37.9% — against Q3 FY2025
Read the filingWrite down why you are following Dolby Laboratories, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 4 subsidiaries named in its 10-K, incorporated across 4 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Source: Exhibit 21 of the 10-K filed 2025-11-18. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from DLB's 10-K for fiscal year 2025 (period ending 2025-09-26, filed Nov 18, 2025), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 8 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 7.3 | 6/8 | 10-K, filed Nov 18, 2025 |
| FY2024 | 6.0 | 6/8 | 10-K, filed Nov 19, 2024 |
| FY2023 | 7.3 | 5/8 | 10-K, filed Nov 17, 2023 |
| FY2022 | 6.0 | 5/8 | 10-K, filed Nov 18, 2022 |
| FY2021 | 7.3 | 7/8 | 10-K, filed Nov 17, 2021 |
| FY2020 | 6.0 | 6/8 | 10-K, filed Nov 16, 2020 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
6 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +45.6%
$482.0M to $701.9MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: +21.1%
$30.0M to $36.3MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Improved: +5.9%
$1.27B to $1.35BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: −1.7 pts
20.6% to 18.9%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Changed: +10.5%
$114.6M to $126.6MNotable
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Q3 FY2026 against Q3 FY2025, from the 10-Q filed Jul 30, 2026 — read it.
Deteriorated: -28.0%
$47.6M to $34.3MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -37.9%
$46.1M to $28.6MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −3.9 pts
15.1% to 11.3%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −5.2 pts
14.6% to 9.4%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -36.8%
$0.48 to $0.30Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: -1.7%
95.9M to 94.2MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q3 FY2026 against Q2 FY2026, from the 10-Q filed Jul 30, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -69.6%
$112.9M to $34.3MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: -69.9%
$94.9M to $28.6MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −17.3 pts
28.5% to 11.3%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: −14.6 pts
24.0% to 9.4%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -69.6%
$1.00 to $0.30Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -22.9%
$395.6M to $305.0MSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: -24.6%
$350.9M to $264.7MSignificant
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Deteriorated: −1.9 pts
88.7% to 86.8%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +12.6%
$594.3M to $669.4MNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -1.0%
95.2M to 94.2MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
7 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 6.2% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 26.8x — investors pay $26.8 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| 23.42x |
| 0.23x |
| PATHUiPath, Inc. | 8.7/10 | 7/8 | 12.7% | 17.5% | 26.57x | 0.53x |
|---|
| Median of peers | 8.7/10 | — | 12.7% | 17.5% | 26.57x | 0.53x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Sold on the open market — 836 shares at $59.33 ($49.6K)
Holds 166,803 shares after this filing.
Was granted or awarded shares — 48,076 shares
Holds 119,024 shares after this filing.
Was granted or awarded shares — 48,076 shares
Holds 166,803 shares after this filing.
Was granted or awarded shares — 160,256 shares
Holds 160,256 shares after this filing.
Exercised stock options — 7,667 shares at $45.50 ($348.8K)
Holds 126,394 shares after this filing.
Sold on the open market — 7,667 shares at $61.05 ($468.0K)
Holds 118,727 shares after this filing.
Converted a derivative security — 300,000 shares
Holds 300,000 shares after this filing.
Gifted shares — 300,000 shares
Holds 0 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 7,667 shares ($450.7K) on or after .
Shares originally obtained via Stock Option Exercise.
Filed notice to sell 7,667 shares ($468.0K) on or after .
Shares originally obtained via Stock Option Exercise.
Filed notice to sell 1,183 shares ($77.2K) on or after .
Shares originally obtained via Restricted Stock.
Filed notice to sell 3,000 shares ($188.1K) on or after .
Shares originally obtained via Restricted Stock.
Filed notice to sell 1,348 shares ($83.6K) on or after .
Shares originally obtained via Restricted Stock.
Filed notice to sell 7,667 shares ($460.0K) on or after .
Shares originally obtained via Stock Option Exercise.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results · Reported another event
Quarterly report for Q2 FY2026
Revenue +7.1% · Gross profit +5.1% · Gross margin −1.6 pts — against Q2 FY2025
Read the filingPublished results · Reported another event
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Operating margin −4.5 pts · Free cash flow -49.8% · Operating income -22.2% — against Q1 FY2025
Read the filingPublished results · Reported another event
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue +5.9% · Profit margin −1.7 pts · Free cash flow +46.6% — against FY2024
Read the filingPublished results · Reported another event
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q3 FY2025
Revenue +9.3% · Operating margin +2.4 pts · Operating income +29.5% — against Q3 FY2024
Read the filingPublished results · Reported another event
Read the filingQuarterly report for Q2 FY2025
Profit margin −2.0 pts · Profit -6.2% · Earnings per share -6.8% — against Q2 FY2024
Read the filingPublished results · Reported another event
Read the filingAmended its charter or changed its financial year · Held a shareholder vote
Read the filingQuarterly report for Q1 FY2025
Read the filingPublished results · Reported another event
Read the filingProxy statement for a shareholder meeting
Read the filingCoverage from the last 30 days
Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
Yahoo Finance ·
How Meta’s Expanded Dolby Atmos and Vision Integration At Dolby Laboratories (DLB) Has Changed Its Investment Story
Yahoo Finance ·
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
Yahoo Finance ·
Whispp Appoints Former Dolby Executive Andreas Spechtler as CEO
Yahoo Finance ·
Here’s Why the Fund Exits Dolby Laboratories (DLB)
Yahoo Finance ·
Here’s Why Dolby Laboratories (DLB) Traded Down in Q2
Yahoo Finance ·
Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan
Yahoo Finance ·
Can Rising Component Costs and Weak Consumer Spending Break Dolby Laboratories’ (DLB) Growth Outlook?
Yahoo Finance ·
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
Yahoo Finance ·
Zacks Industry Outlook Highlights Sony, Dolby Laboratories and Sonos
Yahoo Finance ·
Your Meta AI Glasses Are Getting a Dolby Upgrade
Yahoo Finance ·
Is Meta (META) Quietly Rewriting Its Hardware Strategy Through Muse-Powered Ray-Ban AI Glasses?
Yahoo Finance ·
Primary sources and further research